Tatva Chintan Pharma Chem Limited · NSE:TATVA
Tatva Chintan Pharma Chem — Q2 FY25 and H1 FY25 Earnings Presentation
38 slides from Tatva Chintan Pharma Chem's earnings presentation, Oct 25, 2024
Slide 1: Exchange filing cover letter: Investor Presentation
Date: 25 October 2024 Ref. No.: TCPCL/SEC/2024-25/00053 To, The General Manager, The Manager, Corporate relationship department, Listing department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Fort, Bandra-Kurla Complex,
Slide 2: Investor Presentation Q2FY25 & H1FY25
Investor Presentation Tatva Chintan Pharma Chem Limited (TCPCL) Q2FY25 & H1FY25 25 October 2024
Slide 3: Contents
Contents 01 02 03 04 Q2FY25 & H1FY25 TATVA CHINTAN at Glance Product Categories Leading Sustainable Financial Performance practices coupled with cutting edge technology 05 06 07 08 Expansive international Why TATVA CHINTAN Industry Outlook Our Business presence with Marquee clientele 2
Slide 4: Consolidated Financial Performance
Consolidated Financial Performance 3
Slide 5: Q2FY25 & H1FY25: Financial Result highlights
Q2FY25 & H1FY25: Financial Result highlights Q2FY25 HIGHLIGHTS EBIDTA (Excl. Other Income) & PAT & PAT Margin 1 (In ₹ Mn, %) EPS (In ₹) Revenue from Operations 1 (In ₹ Mn) 4.0 0 EBIDTA Margin 1 (In ₹ Mn, %) 250 25. 0% 3.5 0 21.0% 3.0 0 90 200 20. 0% 80 8.0% 11.0% 9.0% 2.5 0 70 4.9% 7.0% 12.0% 2.0 0
Slide 6: Q2FY25 & H1FY25: Consolidated P&L
Q2FY25 & H1FY25: Consolidated P&L Particulars (₹ Mn) Q2FY25 Q2FY24 YoY (%) Q1FY25 QoQ (%) H1FY25 H1FY24 YoY (%) Revenue from Operation 834.90 966.69 -13.63% 1,054.64 -20.84% 1,889.54 2,110.33 -10.46% Total Income 838.67 974.25 -13.92% 1,066.37 -21.35% 1,905.04 2,128.04 -10.48% EBITDA (Excl. Other In
Slide 7: Q2FY25 & H1FY25: Operational highlights
Q2FY25 & H1FY25: Operational highlights OPERATING REVENUE SPLIT (IN %) Q2FY25 H1FY25 PTC 32.9% PTC 30.3% SDA 32.4% SDA 32.9% ELECTROLYTE SALTS 1.5% ELECTROLYTE SALTS 1.4% PASC 32.6% PASC 35.0% OTHERS 0.6% OTHERS 0.5% Tatva Chintan Pharma Chem Limited 6
Slide 8: Chairman & MD's Comments on Results
Chairman & MD’s Comments on Results “ We continue to grow organically by incorporating innovative ideas across operations and increasing our product portfolio across product categories. “ Mr. Chintan Shah CMD TAT V A C H I N TA N P H A R M A CHEM LIMITED • During Q2FY25, the company reported revenue
Slide 9: Consolidated Financial Highlights
Consolidated Financial Highlights REVENUE FROM OPERATIONS1 (IN ₹ MN) PROFITABILITY1 (IN ₹ MN) EBITDA (Excluding Other Income) & EBITDA Margin PAT & PAT Margin 90 57 75 22% 25% 14% 17% 10% 17% 22% 11% 8% 2% 52 4,336 4,236 3,935 16 3,004 1,082 959 14% 15% 8% 304 1,890 682 182 664 CAGR* CAGR* 523 45 60
Slide 10: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss As at Particulars (₹ Mn) 31 March 2020 31 March 2021 31 March 2022 31 March 2023 31 March 2024 30 Sep 2024 Audited Audited Audited Audited Audited Un - Audited Income Revenue from operations 2,632.39 3,003.59 4,336.47 4,236.12 3,935.04 1,889.54 Total Income 2,
Slide 11: Consolidated Statement of Balance Sheet
Consolidated Statement of Balance Sheet As at Particulars (₹ Mn) 31 March 2020 31 March 2021 31 March 2022 31 March 2023 31 March 2024 30 Sep 2024 Audited Audited Audited Audited Audited Un – Audited Assets Fixed Assets 1,110.60 1,203.51 1,592.96 1,957.71 4,265.35 4,209.24 Capital work-in-progress 4
Slide 12: TATVA CHINTAN at Glance
TATVA CHINTAN at Glance 11
Slide 13: TATVA CHINTAN at Glance
TATVA CHINTAN at Glance INTEGRATED SPECIALTY CHEMICAL COMPANY, PRESENT ACROSS THE VALUE CHAIN • Established by first generation entrepreneur engineers in Manufacturing Products Revenue Split – FY24 1996 • Plants located at Ankleshwar and Dahej SEZ, Gujarat with an existing combined installed reactor
Slide 14: Product Categories
Product Categories » & =< i ©
Slide 15: Phase Transfer Catalyst (PTC) – a Catalyst with Innumerable Benefits
Phase Transfer Catalyst (PTC) – a Catalyst with Innumerable Benefits WHAT ARE PTC? BENEFITS DEMAND DRIVERS • PTC are used to facilitate the • Offers faster reactions • Rising demand for technologically TATVA CHINTAN’S migration of a reactant from one • Higher conversion or yields, advanced environme
Slide 16: Structure Directing Agents (SDA)
Structure Directing Agents (SDA) – an important ingredient for making the world more sustainable WHAT ARE SDA? BENEFITS DEMAND DRIVERS • High purity Quaternary salts that SDAs are important raw material for • With the recent developments in TATVA CHINTAN’S helps in the formation of creation of high
Slide 17: Electrolysis – a better and greener way of producing SDAs
Electrolysis – a better and greener way of producing SDAs ABOUT ELECTROLYSIS BENEFITS • TATVA started R&D into developing SDAs • Electrolysis is considered as a ‘green’ since 2007 chemistry process wherein apart from a single starting raw material, the process largely uses • In 2015, it received com
Slide 18: Electrolyte Salts – aiding the technological thrust
Electrolyte Salts – aiding the technological thrust WHAT ARE ELECTROLYTE BENEFITS DEMAND DRIVERS • Due to their properties like fast TATVA CHINTAN’S SALTS? Currently, these are used along with charging ability, superior low Lithium battery in EV vehicles PRESENCE IN SALTS • Electrolyte Salts are use
Slide 19: Pharmaceuticals and Agrochemicals Intermediates and other Specialty Chemicals (PASC)
Pharmaceuticals and Agrochemicals Intermediates and other Specialty Chemicals (PASC) – WHICH PRODUCTS ARE END USER INDUSTRY TATVA CHINTAN’S TATVA is the largest MANUFACTURED? APPLICATION POSITION IN PASC producer of Glymes in India and third • Various pharmaceutical and agrochemical products such as
Slide 20: Continuous Flow Chemistry
Continuous Flow Chemistry – sophisticated method with analytical expertise ABOUT BENEFITS PROCESS • TATVA CHINTAN started R&D into • Continuous Flow Chemistry is • Structure directing agents are continuous flow chemistry since considered as a ‘green’ chemistry converted to Zeolite based catalysts 20
Slide 21: Value derived from Product Categories
Value derived from Product Categories REVENUE FROM EACH PRODUCT CATEGORY1 (In ₹ Mn.) 2,248 Considering the wide range of applications of our products, Tatva Chintan can cater to 1,655 customers across wide spectrum of Chemical Industries which ensures a 1,432 1,335 1,277 sustainable business model.
Slide 22: Leading Sustainable practices coupled with cutting edge technology
Leading Sustainable practices coupled with cutting edge technology 21
Slide 23: Integrated and Modern Manufacturing Facility
Integrated and Modern Manufacturing Facility ANKLESHWAR DAHEJ SEZ • Both the plants are in-close proximity to • Manufacturing facility started in 1996 • Manufacturing started in 2017 Hazira port. • Converted into a ‘zero liquid effluent discharge’ facility from • Company has having sophisticated qua
Slide 24: One of the prominent Research & Development center
One of the prominent Research & Development center R&D CAPITAL AND REVENUE EXPENDITURE • Dedicated R&D facility at Vadodara recognized by the Department of (In ₹ Mn.) 300 .00 Scientific and Industrial Research (“DSIR”), Government of India. • Equipped with glass assemblies, continuous flow reactors,
Slide 25: With a focus on 'green' chemistry processes
…With a focus on ‘green’ chemistry processes Tatva Chintan’s ‘green’ chemistry is based on the principles of clean chemistry, minimum requirement of auxiliary substances, minimum waste and by-products and safe chemistry • Undertaking various ‘green’ chemistry processes • By deploying electrolysis fo
Slide 26: Expansive international presence with Marquee clientele
Expansive international presence with Marquee clientele 25
Slide 27: Fostered long term relationship with marquee clientele
Fostered long term relationship with marquee clientele while continuously expanding presence in global market ESTEEMED CUSTOMERS EXPORTS • Tatva exports products to over 25+ countries viz. USA, China, Germany, Japan, South Africa and UK. • Subsidiaries facilitates overseas operations:- • Tatva Chint
Slide 28: Why TATVA CHINTAN
Ze Why TATVA . CHINTAN @
Slide 29: Investment Rationale
Investment Rationale Presence in niche Track record of Wide basket of Continuous focus High industry Capex to boost the specialty chemicals developing wide products are used in on R&D and in house barriers as new capacities and pave space with limited product basket varied industries developed entra
Slide 30: Industry Outlook
Industry Outlook 29
Slide 31: India's rapidly expanding footprint in Global Chemical Market
India's rapidly expanding footprint in Global Chemical Market SHARE OF COUNTRIES IN GLOBAL TRENDS IN SPECIALTY CHEMICALS LANDSCAPE CHEMICAL INDUSTRY (IN %) Indian Chemical Move towards Opportunity Industry got sustainable product for Indian Advantage vs development: Manufacturers: CHINA 39% China du
Slide 32: Global Chemical Industry
Global Chemical Industry GLOBAL PTC SDA CHEMICAL Commodity Chemicals INDUSTRY • Basic Chemicals 1,190 1.19 MARKET SIZE • Manufactured In large volumes Mkt Size 2022 (USD Mn) Mkt Size 2022 (USD bn) • Mkt Size USD 3,700bn • ~Expected 4% CAGR 1,640 5.5% 1.65 5.6% 5,030 Speciality Chemicals Mkt Size 202
Slide 33: Our Business
Our Business 32
Slide 34: Major Events & Milestones
Major Events & Milestones 1996 2007 2013 2017 2019 2021 Incorporation of our Expansion of Achieved turnover Set up our Dahej SEZ Incorporation of • Listed on Company manufacturing capacity at of ₹ 500.00 million Manufacturing Facility Tatva Chintan Europe BSE and NSE our Ankleshwar BV, a wholly owne
Slide 35: Leadership and Management
Leadership and Management Chintan Nitinkumar Ajaykumar Shekhar Rasiklal Dr. Manher Chimanlal CA Subhash Dr. Avani Rajesh Shah Mansukhlal Patel Somani Desai Ambubhai Patel Umatt M ANA G I N G D I R E C T O R WHOLE TIME DIRECTOR WHOLE TIME DIRECTOR I ND E P E ND E NT D I R E C T O R I ND E P E ND E NT
Slide 36: Shareholder Information
Shareholder Information SHAREHOLDING PATTERN- Sep 2024 (IN %) NSE Ticker TATVA BSE Ticker 543321 IPO Listing Date 29 July 2021 Share Price (₹)^ 1,051 PROMOTER 72.02% Market Cap (₹ Mn)^ 24,578 MF 6.76% % Free Float^ 27.98% Sep PUBLIC 17.23% Free float market cap (₹ Mn)^ 6,877 2024 FPI 3.33% Shares ou
Slide 37: Safe Harbor
Safe Harbor Certain statements in this presentation concerning our future growth prospects are forward looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company's results may
Slide 38: Thank You
October 2024 Thank You TATVA CHINTAN PHARMA CHEM LIMITED INVESTOR RELATIONS AT CORPORATE OFFICE TATVA CHINTAN Plot No. 353, G.I.D.C, Mr. Ashok Bothra Makarpura, Vadodara – 390 010, Gujarat, India finance@tatvachintan.com BSE: 543321 EY NSE: TATVA Ms. Krishna Patel | Mr. Arpit Mundra CIN: L24232GJ199
Tatva Chintan Pharma Chem — Q2 FY25 and H1 FY25 Earnings Presentation on 6ix